Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 2
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(2)
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02157701Phase 4Completed

Polyherbal Capsule Formulation for Joint Health

Role: lead

NCT02157675Phase 4Completed

Effects of a Polyherbal Supplement on the Signs and Symptoms of Delayed Onset Muscle Soreness

Role: lead

NCT02146157Not ApplicableCompleted

Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes

Role: lead

NCT01554020Phase 2Withdrawn

Blood Sugar Take Care and Glucose Metabolism

Role: lead

All 4 trials loaded